Search research articles
Contact Us
Filters
Showing results (31-40 of 233) with videos related to
Page
of 24
Sort By:
Therapeutic Advances in Medical Oncology
|
July 27, 2011
The role of peri-operative treatment in resectable liver metastases of colorectal cancer
Alexander Stein, Joern Rüssel, Stefan Peinert, et al.
Clinical Colorectal Cancer
|
September 9, 2020
Severe Nonbacterial Thrombotic Endocarditis Resulting in Aortic Valve Insufficiency and Multiple Small Strokes in a Patient With Metastatic Pancreatic Cancer: Lessons for Optimal Management
Maike Collienne, Martin Kuhns, Hans-Peter Hauber, et al.
The Oncologist
|
June 24, 2006
Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review
Dirk Arnold, Stefan Peinert, Wieland Voigt, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology
|
October 18, 2005
Evolutionary aspects and muscular properties of the trunk--implications for human low back pain
Nadja Schilling, Dirk Arnold, Heiko Wagner, et al.
Scientific Reports
|
December 9, 2025
Control of limb loading during active horizontal perturbations at moderate and fast trots in rats
Emanuel Andrada, Martin S Fischer, Heiko Stark, et al.
Future Oncology (London, England)
|
July 7, 2022
GOBLET: a phase I/II study of pelareorep and atezolizumab +/- chemo in advanced or metastatic gastrointestinal cancers
Maike Collienne, Houra Loghmani, Thomas Charles Heineman, et al.
Therapeutic Advances in Medical Oncology
|
March 23, 2023
Time for a lead-time definition? Author response to 'Why the length of recurrence free survival or "lead-times" can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis'
Karen-Lise Garm Spindler, Louise Bach Callesen, Dirk Arnold
Cancer Investigation
|
May 28, 2010
Optimizing the use of sunitinib in metastatic renal cell carcinoma: an update from clinical practice
Manuela Schmidinger, Dirk Arnold, Cezary Szczylik, et al.
Radiation Oncology (London, England)
|
June 12, 2012
Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study
Kathrin Dellas, Thomas Reese, Michael Richter, et al.
Scientific Reports
|
May 27, 2024
Impact of functional electrical stimulation on nerve-damaged muscles by quantifying fat infiltration using deep learning
Kassandra Walluks, Jan-Philipp Praetorius, Dirk Arnold, et al.
Page
of 24
Search research articles
Search
Showing results (31-40 of 233) with videos related to
Sort By:
Page
of 24
Therapeutic Advances in Medical Oncology
|
July 27, 2011
The role of peri-operative treatment in resectable liver metastases of colorectal cancer
Alexander Stein, Joern Rüssel, Stefan Peinert, et al.
Clinical Colorectal Cancer
|
September 9, 2020
Severe Nonbacterial Thrombotic Endocarditis Resulting in Aortic Valve Insufficiency and Multiple Small Strokes in a Patient With Metastatic Pancreatic Cancer: Lessons for Optimal Management
Maike Collienne, Martin Kuhns, Hans-Peter Hauber, et al.
The Oncologist
|
June 24, 2006
Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review
Dirk Arnold, Stefan Peinert, Wieland Voigt, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology
|
October 18, 2005
Evolutionary aspects and muscular properties of the trunk--implications for human low back pain
Nadja Schilling, Dirk Arnold, Heiko Wagner, et al.
Scientific Reports
|
December 9, 2025
Control of limb loading during active horizontal perturbations at moderate and fast trots in rats
Emanuel Andrada, Martin S Fischer, Heiko Stark, et al.
Future Oncology (London, England)
|
July 7, 2022
GOBLET: a phase I/II study of pelareorep and atezolizumab +/- chemo in advanced or metastatic gastrointestinal cancers
Maike Collienne, Houra Loghmani, Thomas Charles Heineman, et al.
Therapeutic Advances in Medical Oncology
|
March 23, 2023
Time for a lead-time definition? Author response to 'Why the length of recurrence free survival or "lead-times" can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis'
Karen-Lise Garm Spindler, Louise Bach Callesen, Dirk Arnold
Cancer Investigation
|
May 28, 2010
Optimizing the use of sunitinib in metastatic renal cell carcinoma: an update from clinical practice
Manuela Schmidinger, Dirk Arnold, Cezary Szczylik, et al.
Radiation Oncology (London, England)
|
June 12, 2012
Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study
Kathrin Dellas, Thomas Reese, Michael Richter, et al.
Scientific Reports
|
May 27, 2024
Impact of functional electrical stimulation on nerve-damaged muscles by quantifying fat infiltration using deep learning
Kassandra Walluks, Jan-Philipp Praetorius, Dirk Arnold, et al.
Page
of 24